C4x Discovery Share Discussion Threads

[rafboy] 11/4/2019 10:59

The company not commenting causes a vacuum and brings uncertainty even if there should be none. So people rest on their hands instead of buying. Just my view.

[alloa2003] 11/4/2019 10:56

Surprised at the lack of comment on this one. Still offer good value in my book.

[rafboy] 10/4/2019 15:02

Oh well let’s hope this blows over fairly quickly.

[alloa2003] 10/4/2019 14:59

I see where you are coming from Rafa but I think if there is nothing to say dont say anything. Not sure about the 20% price movement statements nowadays, I know there used to be something like that in the past.

Lets not forget the shares were lower than this just a couple of weeks ago.

[rafboy] 10/4/2019 14:56

Alloa, fair point. My only concern would be that the lack of a statement may give some credence to the more fanciful negative comments. Also, if it falls much further are they not obliged to say something at the minus 20% level?

[alloa2003] 10/4/2019 14:54

Mammyoko

"Fact remains that the decline in this share has tracked the decline in INDV"

A blatant attempt to hoodwink people. You know as well as I do that the share price fall was down to the 1.5m share holder going into liquidation and being a forced seller.

Why are you trying to mislead people?

[alloa2003] 10/4/2019 14:52

Rafboy - I would not expect a statement. I spoke with the PR people earlier and they couldnt say much but said if it made a material difference to C4XD then they would have made a statement. The fact they havent says everything.

Yes, a statement would clear up some of the wild rumours but if you start responding to every rumour, etc then you make a rod for your own back. Then when you dont respond to one rumour the markets goes into meltdown. If there is nothing to say then the company is quite right to say nothing.

[rafboy] 10/4/2019 14:49

However, a statement from the company would be good at this point.

[richardjohn10] 10/4/2019 14:31

Clueless little trolls

[trotterstrading] 10/4/2019 14:21

Few new posters attempting to scare a few weak hands. Seen it all before INDV is not the ONLY funder at all, you sir/Madame are taking out of your backside. Indeed they raised £10m from II's back in Nov without issue and at minimal discount, the CEO is on record stating they have a cash run way to last them "well into 2020"

[mammyoko] 10/4/2019 14:15

Fact remains that the decline in this share has tracked the decline in INDV, it's only significant funder. The two are clearly not unconnected. C4XD needs another deal quickly to replace the INDV one which is now dead or the price will continue to drift down

[alloa2003] 10/4/2019 14:08

If C4XD has the licence then:-

- it has some sell on value in the event that INDV fail
- they can appoint another partner if INDV fail

Unless I am mistaken it is C4XD which hold the IP rights to the new molecule not INDV which only sells under licence?

Yes, obviously this might impact payments to C4XD. However, mammyoko your post is misleading. You are quoting cash in the bank now - nobody said or expected this max $294m to be paid in one go and it is not even guaranteed. From what I read that is the max payout.

[trotterstrading] 10/4/2019 14:04

Sellers getting mugged at the lows.. same old story. Sigh

[trotterstrading] 10/4/2019 13:51

The whole business model of C4 is not to be reliant on one or even two molecules, the INDV situation is unfortunate and undoubtedly delays any further milestones for C4, but it doesn't warrant the fall in share price IMHO. Near term share price catalysts are their two lead molecules which are at partnering discussion phase, get those over the line the share price will be closer to £2 than £1 IMHO

[pugg1ey] 10/4/2019 13:49

Court case is over a year away and they have a reasonable cash pile set aside already so no immediate trouble. perhaps they'll take it forward it more aggressively as a means to improving the share price

[ewanwhose] 10/4/2019 13:31

I'm talking about the C4XD compound that INDV have licensed. We are due stage payments of up to $284M - if INDV get into serious trouble they may not take this forwards as aggressively or at all.

[mammyoko] 10/4/2019 13:30

Take a look at INDV's latest Balance Sheet. They only have $249m 'available'. No way they are going to be putting much of that towards the $294m C4XD advertised last year. If any. They are going to need all they can to fight the DoJ $1.5bn claim on them. That's if they don't go into administration first. They have negative NTAV so wouldn't bank on an equity raise providing a way out. The reality is that that deal is history and C4XD need another to keep the lights on

$
Cash $924
Receivables $287
Current borrowings $(4)
Trade & other payables $(721)
Non-current borrowings $(237)
$249

Net equity $66
Less: Intangibles $(84)
Potential provision??? $(250)

Negative NTAV $(268)

[mammyoko] 10/4/2019 13:24

RB. are on the hook for 50% of the costs of any payout to DoJ

[alloa2003] 10/4/2019 13:23

How are INDV payments in jeopady - from my understanding the drug involved is not the one C4XD have been working on. If there were any major issues someone would simply buy the licence for the drug - there may even be repatriation small print in the deal with C4XD.

I think this is over blown.

Spoke to the PR company and while they couldnt say much he kept saying "If there was a material impact then C4XD would have made a stockmarket RNS". So....

[purple11] 10/4/2019 13:23

well that's the end of that then.lol

[ewanwhose] 10/4/2019 13:19

RB. was sold down as well on the INDV news even though they gave no liability.

[rafboy] 10/4/2019 13:15

Not nice though seeing the drop. I wonder if the company will comment.

[ewanwhose] 10/4/2019 13:15

Don't disagree, but the counter argument would be that the price yesterday was expecting further payments from INDV which are now in jeopardy so the share price should logically fall.

[trotterstrading] 10/4/2019 13:12

You know how the saying goes... fools and their money